These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 3362880)

  • 1. Flow cytometry correlates of response to intravesical interferon.
    Bonney WW; Rosenberg SJ; Kluskens LF; Yen A; Henry KM; Williams RD
    Prog Clin Biol Res; 1988; 260():203-14. PubMed ID: 3362880
    [No Abstract]   [Full Text] [Related]  

  • 2. Intravesical therapy: does it affect the natural history of superficial bladder cancer?
    Lamm DL; Griffith JG
    Semin Urol; 1992 Feb; 10(1):39-44. PubMed ID: 1565903
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immunotherapy of urothelial neoplasms. Experimental and clinical implications of alpha interferon].
    Carballido J; Alvarez-Mon M; Olivier C; Moltó L
    Arch Esp Urol; 1990; 43 Suppl 2():149-58. PubMed ID: 2096776
    [No Abstract]   [Full Text] [Related]  

  • 4. Intravesical interferon alfa in the treatment of superficial bladder cancer.
    Williams RD
    Semin Oncol; 1988 Oct; 15(5 Suppl 5):10-3. PubMed ID: 3057641
    [No Abstract]   [Full Text] [Related]  

  • 5. Management of superficial transitional cell carcinoma of the bladder.
    Fleischmann J; Goldberg G
    Semin Urol; 1993 Nov; 11(4):193-204. PubMed ID: 8290825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment and follow-up of superficial bladder cancer].
    Raitanen M
    Duodecim; 2002; 118(9):903-9. PubMed ID: 12238168
    [No Abstract]   [Full Text] [Related]  

  • 7. Intravesical therapy for superficial bladder cancer.
    Malkowicz SB
    Semin Urol Oncol; 2000 Nov; 18(4):280-8. PubMed ID: 11101091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravesical interferon treatment of superficial bladder cancer.
    Chodak GW
    Urology; 1989 Oct; 34(4 Suppl):84-6; discussion 87-96. PubMed ID: 2678688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Intravesical chemotherapy with interferon in superficial bladder tumors].
    Tanahashi T; Matsumura Y; Yoshimoto J; Tsushima T; Obama T; Akagi T; Ochi J; Hara M; Saegusa M; Ohmori H
    Gan To Kagaku Ryoho; 1987 Apr; 14(4):1156-9. PubMed ID: 3105469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Squamous cell carcinoma of the urinary bladder after intravesical bacillus Calmette-Guerin therapy for carcinoma in situ: a case report].
    Uemura M; Nishimura K; Nakagawa M; Kanno N; Miyoshi S; Kawano K; Inoue H
    Hinyokika Kiyo; 2004 Nov; 50(11):809-11. PubMed ID: 15628544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of superficial bladder tumors].
    Chopin DK
    Rev Prat; 1997 Feb; 47(4):382-7. PubMed ID: 9114523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dilemmas in the management of carcinoma-in-situ of the urinary bladder.
    Aigen AB
    Mt Sinai J Med; 1982; 49(1):78-82. PubMed ID: 6979690
    [No Abstract]   [Full Text] [Related]  

  • 13. Combined local bladder hyperthermia and intravesical chemotherapy for the treatment of high-grade superficial bladder cancer.
    Gofrit ON; Shapiro A; Pode D; Sidi A; Nativ O; Leib Z; Witjes JA; van der Heijden AG; Naspro R; Colombo R
    Urology; 2004 Mar; 63(3):466-71. PubMed ID: 15028439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha-interferon in superficial bladder cancer: a Northern California Oncology Group Study.
    Torti FM; Shortliffe LD; Williams RD; Pitts WC; Kempson RL; Ross JC; Palmer J; Meyers F; Ferrari M; Hannigan J
    J Clin Oncol; 1988 Mar; 6(3):476-83. PubMed ID: 3280742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Biological response modifiers and their use in urology: our experience].
    Fontana G; Bozzo R; Sesia G; Cavallo GP; Forni G
    G Batteriol Virol Immunol; 1989; 82(1-12):39-47. PubMed ID: 2518762
    [No Abstract]   [Full Text] [Related]  

  • 16. [Conservative treatment of superficial transitional cell carcinoma of the bladder].
    Gruenwald I; Stein A; Lurie A
    Harefuah; 1995 Jan; 128(2):104-11. PubMed ID: 7721171
    [No Abstract]   [Full Text] [Related]  

  • 17. Superficial transitional (Ta/T1/CIS) cell carcinoma of the bladder.
    Konety BR; Williams RD
    BJU Int; 2004 Jul; 94(1):18-21. PubMed ID: 15217424
    [No Abstract]   [Full Text] [Related]  

  • 18. Intravesical bacille Calmette-Guérin induces the antiangiogenic chemokine interferon-inducible protein 10.
    Poppas DP; Pavlovich CP; Folkman J; Voest EE; Chen X; Luster AD; O'Donnell MA
    Urology; 1998 Aug; 52(2):268-75; discussion 275-6. PubMed ID: 9697793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-risk superficial bladder cancer: intravesical therapy for T1 G3 transitional cell carcinoma of the urinary bladder.
    Pham HT; Soloway MS
    Semin Urol Oncol; 1997 Aug; 15(3):147-53. PubMed ID: 9394909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical trials of human leukocyte interferon in malignancy.
    Hill NO; Pardue A; Khan A; Aleman C; Hilario R; Hill JM
    Tex Rep Biol Med; 1981-1982; 41():634-40. PubMed ID: 6763370
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.